Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
9.84
-0.65 (-6.20%)
At close: Nov 17, 2026, 4:00 PM EST
10.14
+0.30 (3.09%)
After-hours: Nov 17, 2026, 7:50 PM EST

Generate Biomedicines Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Generate Biomedicines stock has a consensus rating of "Strong Buy" and an average price target of $27. The average 1-year stock price forecast is 174.39% higher than the current stock price, while the lowest is $22 (+123.58%) and the highest is $30 (+204.88%).

Price Target: $27 (+174.39%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$22$27$27$30
Change+123.58%+174.39%+174.39%+204.88%

Analyst Ratings

The average analyst rating for Generate Biomedicines stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingApr '26May '26Aug '26Sep '26Oct '26Nov '26
Strong Buy444443
Buy222222
Hold000000
Sell000000
Strong Sell000000
Total666665

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$25 → $30
BuyReiterates$25 → $30+204.88%Nov 13, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$26
BuyReiterates$26+164.23%Oct 14, 2026
Morgan Stanley
Morgan Stanley
Buy
Reiterates
$22
BuyReiterates$22+123.58%Aug 17, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$30
BuyReiterates$30+204.88%Jun 25, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
24.82M
from 31.89M
Decreased by -22.17%
Revenue Next Year
24.00M
from 24.82M
Decreased by -3.31%
EPS This Year
-2.45
EPS Next Year
-2.38
from -2.45
Fiscal YearFY 2024FY 2025FY 2026
Period EndingDec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
20.46M31.89M24.82M
Revenue Growth
-55.89%-22.17%
Operating Income
-196.94M-235.07M-296.44M
Net Income
-173.77M-203.15M-297.07M
EPS
---2.45
Free Cash Flow
---260.00M
No. Analysts
--5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High27.8M
Avg24.8M
Low22.0M

Revenue Growth

Revenue Growth202620272028
High
-12.8%
Avg
-22.2%
Low
-31.0%

EPS Forecast

EPS202620272028
High-2.40
Avg-2.45
Low-2.50

EPS Growth

EPS Growth20272028
High-
Avg-
Low-